Clinical analysis of rabeprazole in the treatment of patients with chronic gastritis
雷贝拉唑治疗慢性胃炎患者的临床分析

摘要

目的 分析对慢性胃炎患者应用雷贝拉唑治疗的效果。方法 将2021年10月-2023年10月于我院就诊的慢性胃炎患者80例分对照组和观察组各40例，对照组常规治疗，观察组增加雷贝拉唑，对比两组患者治疗前后的炎性因子指标、临床症状治疗效果、治疗满意度；结果 治疗前，两组炎性因子指标、临床症状效果指标差异不显著，P﹥0.05，护理后观察组炎性因子更低，临床症状改善效果更优，患者治疗满意度高于对照组，差异显著，P﹤0.05。结论 对慢性胃炎患者实施雷贝拉唑的治疗效果较好，可抑制胃酸分泌，降低炎性因子水平，利于疾病症状改善，同时患者治疗体验较佳，满意度高。

Abstract

Objective To analyze the effect of rabeprazole therapy on chronic gastritis.
Methods 80 patients with chronic gastritis 2021 from October to October in our hospital were divided into control group and an observation group with 40 cases in each group. The control group was treated with routine treatment, while the observation group was treated with increasing rabeprazole.
Results before and after treatment, there was no significant difference in the indexes of inflammatory factors and clinical symptoms between the two groups (P > 0.05), after nursing, the inflammatory factors in the observation group were lower, the clinical symptoms were improved better, and the satisfaction degree of patients was higher than that of the control group, the difference was significant (p < 0.05).
Conclusion   the therapeutic effect of rabeprazole on chronic gastritis patients is better, which can inhibit gastric acid secretion, reduce the level of inflammatory factors and improve the symptoms of the disease.